MARKET

AQST

AQST

Aquestive Therapeutics
NASDAQ
4.780
+0.020
+0.42%
After Hours: 4.770 -0.01 -0.21% 19:46 10/09 EDT
OPEN
4.780
PREV CLOSE
4.760
HIGH
4.975
LOW
4.740
VOLUME
1.69M
TURNOVER
--
52 WEEK HIGH
7.55
52 WEEK LOW
2.930
MARKET CAP
599.95M
P/E (TTM)
-7.3629
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AQST last week (0928-1002)?
Weekly Report · 5d ago
Aquestive Therapeutics: The Market Is Already Pricing In Anaphylam's Success
Seeking Alpha · 09/30 14:13
Aquestive Therapeutics Adds Veteran Executive to Board
TipRanks · 09/29 11:49
Aquestive Therapeutics appoints Daly to board of directors
TipRanks · 09/29 11:10
Press Release: Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
Dow Jones · 09/29 11:00
Weekly Report: what happened at AQST last week (0921-0925)?
Weekly Report · 09/28 10:19
Aquestive updates investor presentation on pipeline and regulation
TipRanks · 09/25 12:18
Weekly Report: what happened at AQST last week (0914-0918)?
Weekly Report · 09/21 10:19
More
About AQST
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.

Webull offers Aquestive Therapeutics Inc stock information, including NASDAQ: AQST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AQST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AQST stock methods without spending real money on the virtual paper trading platform.